Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of $17 billion and 50,000 employees in 50 countries. Our mission is to enable customers to make the world healthier, cleaner and safer by supporting them to accelerate life sciences research, to solve complex analytical challenges, to improve patient diagnostics and to increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive support. For more information, please visit


Thermo Scientific B·R·A·H·M·S Biomarkers investigates, develops and manufactures novel diagnostic testing procedures to improve early diagnosis and treatment of life threatening diseases. With high-quality immunodiagnostic tests for prenatal screening, cardiovascular, pulmonary, and cancer disorders as well as particularly for sepsis, the company contributes to the creation of a healthier future – to the greatest advantage for medical professionals and patients.


On the basis of completely owned patents and with help of more than 500 employees worldwide, Thermo Scientific B·R·A·H·M·S Biomarkers is leading in specific market places and therapeutic areas. The aim of its basic research is to identify new biomarkers, with support by international co-operations and reputable research institutions. For more information, please visit


Whatever the challenge, we are there

Under the Thermo Scientific brand of Thermo Fisher Scientific, Inc. (NYSE:TMO), we help scientists meet the challenges they face in the lab or in the field every day. From routine analysis to new discoveries, our innovations help professionals do the science they need to do, the way they want to do it. Our high-end analytical instruments, laboratory equipment, software, services, consumables and reagents help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity.


For the latest information about Thermo Fisher Scientific, please visit our corporate news section. To learn about job opportunities that embrace our mission of enabling our customers to make the world healthier, cleaner and safer, please visit our careers section.


Events not available


ICU Management

FDA Grants Emergency Use Authorization for New COVID-19, Flu A, Flu B Combo Kit

2021 16 Feb

One multiplex real-time PCR diagnostic kit can simultaneously detect and differentiate SARS-CoV-2, influenza A and influenza B The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for the  Applied Biosystems TaqPath COVID-19, Flu A, Flu B Combo Kit  from Thermo Fisher Scientific, the company announced today.... Read more

ICU Management

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

2021 19 Jan

Thermo Fisher Scientific Inc . (NYSE: TMO), the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately  $450 million  in cash. Under the terms of the agreement,  Thermo Fisher  will pay up to an additional  $100 million... Read more

ICU Management

FDA Clears Test to Help Manage Antibiotic Treatment For Lower Respiratory Tract Infections & Sepsis

2017 22 Mar

The U.S. Food and Drug Administration today cleared the expanded use of the Vidas Brahms PCT Assay to help health care providers determine if antibiotic treatment should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia, and stopped in patients with sepsis. This is the first test to use... Read more

Jobs not available


    Catalogue not available

Neuendorfstrasse, 25
49 (3302) 883616

White Papers - Case Studies

Not available



Not available


Not available